MARTINELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 728
EU - Europa 347
AS - Asia 143
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1222
Nazione #
US - Stati Uniti d'America 718
IT - Italia 155
CN - Cina 119
NL - Olanda 75
IE - Irlanda 33
FI - Finlandia 23
IN - India 16
UA - Ucraina 16
SE - Svezia 15
CA - Canada 10
DE - Germania 10
GB - Regno Unito 9
ES - Italia 3
IR - Iran 3
EC - Ecuador 2
FR - Francia 2
RU - Federazione Russa 2
BN - Brunei Darussalam 1
BR - Brasile 1
EU - Europa 1
GR - Grecia 1
KR - Corea 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SG - Singapore 1
TR - Turchia 1
Totale 1222
Città #
Chandler 181
Amsterdam 73
Millbury 65
Beijing 46
Des Moines 37
Princeton 33
Boston 32
Napoli 31
Nanjing 28
Lawrence 24
Woodbridge 15
Jacksonville 13
Augusta 12
Nanchang 11
Wilmington 11
Naples 8
Shenyang 8
Changsha 7
Ottawa 7
San Mateo 7
Dublin 5
Hebei 5
Jiaxing 5
Rome 5
Boardman 3
Houston 3
Montecorvino Rovella 3
Oristano 3
Villaricca 3
Casal di Principe 2
Falls Church 2
Groningen 2
Guangzhou 2
Leawood 2
Moscow 2
Norwalk 2
Palermo 2
Redwood City 2
Sant'agnello 2
Stockholm 2
Tianjin 2
Toronto 2
Turin 2
Wuhan 2
A Coruña 1
Alexandria 1
Ann Arbor 1
Ashburn 1
Bandar Seri Begawan 1
Bengaluru 1
Bogen 1
Bologna 1
Brusciano 1
Cagliari 1
Campiglia Marittima 1
Capua 1
Carpi 1
Carugate 1
Caserta 1
Cutrofiano 1
Duncan 1
Fairfield 1
Ferrara 1
Fremont 1
Guadalajara 1
Guayaquil 1
Hangzhou 1
Kunming 1
Lisbon 1
Madrid 1
Manila 1
Milan 1
Mumbai 1
Nagold 1
New York 1
Pagani 1
Pianura 1
Piraeus 1
Quito 1
Redmond 1
Sabz 1
San Francisco 1
San Nicola 1
Scafati 1
Secaucus 1
Treviso 1
Vélizy 1
Warsaw 1
Yellow Springs 1
Totale 759
Nome #
PP-12 EFFICACY OF A STANDARDIZED EXTRACT OF MATRICARIAE CHAMOMILLA L., MELISSA OFFICINALIS L. AND TYNDALLIZED LACTOBACILLUS ACIDOPHILUS (H122) COMPARED WITH LACTOBACILLUS REUTERI (DSM 17938) AND WITH SIMETHICONE FOR THE TREATMENT OF INFANTILE COLIC 60
Effect of Magnesium Alginate Plus Simethicone on Gastroesophageal Reflux in Infants 59
Natural history of pancreatic involvement in paediatric inflammatory bowel disease 57
The Changing Face of Pediatric Ulcerative Colitis: A Population-based Cohort Study 48
20 mm lithium button battery causing an oesophageal perforation in a toddler: Lessons in diagnosis and treatment 41
Yersinia Enterocolitica Ileitis Mimicking Pediatric Crohn's Disease 40
Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study 39
Efficacy of a standardized extract of Matricariae chamomilla L., Melissa officinalis L. and tyndallized Lactobacillus acidophilus (HA122) in infantile colic: An open randomized controlled trial 34
Effectiveness of mediterranean diet’s adherence in children with inflammatory bowel diseases 34
Impact of the Rome II paediatric criteria on the appropriateness of the upper and lower gastrointestinal endoscopy in children. 33
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 32
An Altered Gut Microbiome Profile in a Child Affected by Crohn's Disease Normalized After Nutritional Therapy 30
Impact of hiatal hernia on pediatric dyspeptic symptoms 30
Exclusive enteral nutrition effect on the clinical course of pediatric Crohn’s disease: a single center experience 30
Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis? 29
Diagnostic and therapeutic utility of double-balloon enteroscopy in children 29
Improvement of body composition and bone mineral density after enteral nutrition in pediatric Crohn disease 29
Autophagy genes variants and pediatric Crohn's disease phenotype: a single-center experience. 28
Clostridium difficile and Pediatric Inflammatory Bowel Disease 28
Il trattamento dei disordini funzionali gastrointestinali: Farmaci, fibre, probiotici, terapia comportamentale o altro? 28
Do distinct functional dyspepsia subtypes exist in children? 27
Impact of Environmental and Familial Factors in a Cohort of Pediatric Patients with Inflammatory Bowel Disease 27
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease 27
The role of inflammation on Vitamin D levels in a cohort of pediatric patients with Inflammatory Bowel Disease 26
Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic 24
Nutrition in Paediatric Inflammatory Bowel Disease: A Position Paper on Behalf of The Porto IBD Group of ESPGHAN 23
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis 23
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report 22
Paediatric ulcerative colitis surgery: Italian survey 21
Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. 20
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis 20
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement 20
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease 19
Novel and alternative therapies for childhood constipation 18
Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN 18
Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. 17
Stool Consistency, but Not Frequency, Correlates with Total Gastrointestinal Transit Time in Children 17
Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children 16
Motility Problems in the Intellectually Challenged Child, Adolescent, and Young Adult 15
Colonic Function Investigations in Children: Review by the ESPGHAN Motility Working Group 15
Implementation and Widespread of Inflammatory Bowel Disease Vaccination and Immunization Guidelines: Not an Easy Task 14
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group 14
Serious infectious events and ibuprofen administration in pediatrics: a narrative review in the era of COVID-19 pandemic 14
Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease 13
Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. 12
Prescribing patterns, indications and adverse events of ibuprofen in children: results from a national survey among Italian pediatricians 12
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 11
Poly(C)- binding protein Pcbp2 enables differentiation of definitive erythropoiesis by directing functional splicing of the Runx1 transcript 11
Evaluation of EBV Status and Thiopurine Use in Pediatric Inflammatory Bowel Disease: Time to be a Standard of Care 11
Probiotics' efficacy in paediatric diseases: Which is the evidence? A critical review on behalf of the Italian Society of Pediatrics 10
Foreign body and caustic ingestions in children: A clinical practice guideline: Foreign Bodies and Caustic ingestions in children 10
Implications of splicing alterations in the onset and phenotypic variability of a family with subclinical manifestation of Peutz–Jeghers syndrome: Bioinformatic and molecular evidence 10
Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis 9
Overall Impact of COVID-19 Outbreak in Children with Functional Abdominal Pain Disorders: Results From the First Pandemic Phase 9
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response 6
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group: Impact of the lockdown on IBD management in children 6
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 6
Erratum: Probiotics' efficacy in paediatric diseases: Which is the evidence? A critical review on behalf of the Italian Society of Pediatrics (Ital J Pediatr. (2020) 46 (104) DOI: 10.1186/s13052-020-00862-z) 6
The poly(C)-binding protein Pcbp2 is essential for CD4+ T cell activation and proliferation 4
Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease During COVID-19 Pandemic: A Prospective Study 3
Prevalence of functional gastrointestinal disorders in children with celiac disease on different types of gluten-free diets 3
Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease 3
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease 2
The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study 2
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 2
Totale 1356
Categoria #
all - tutte 3714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20183 0000 00 00 0003
2018/201946 8024 115 72 4102
2019/2020177 59428 222 13 1930216
2020/2021153 5368 2512 1617 812392
2021/2022328 7002 116 77 312189147
2022/2023498 58301824 6849 758 8762361
Totale 1356